|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
Laboratory Report
|
|
|
|||||||||||||||||||||||||
Chemistry
| Test | 20-AUG-2024 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | 4.8 - 5.9 | % |
| Glucose [Mass/volume] in Blood | 64.3 L | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 9.9 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.5 | 0.5 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Blood | 8.7 | 8.6 - 10.3 | mg/dL |
| Sodium [Moles/volume] in Blood | 137.6 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.9 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 101.7 | 96 - 106 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 22.1 | 22 - 29 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 131.4 | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 147.7 | 0 - 149 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 50.7 | 0 - 100 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 51.1 | 40 - 90 | mg/dL |
| Microalbumin/Creatinine [Mass Ratio] in Urine | 8.1 | 0 - 30 | mg/g |
Annotation
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| All measured parameters are within normal limits except for mildly decreased fasting glucose (64.3 mg/dL), which may indicate risk of hypoglycemia and should be clinically correlated. Renal, electrolyte, lipid, and glycemic control markers are unremarkable. No evidence of renal dysfunction or significant dyslipidemia. Overall, laboratory findings are stable. |